JANICE GENNOCRO: Open Payments
NPI 1790364131 · AMHERST, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,354 in 100 payments from 16 companies in 2025. Trend: 2023 $363 · 2024 $707 · 2025 $3,354
Food & beverage: $3,162Education: $192
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 34 | $1,100 |
| ABBVIE INC. | 22 | $579 |
| Madrigal Pharmaceuticals | 4 | $329 |
| Takeda Pharmaceuticals U.S.A., Inc. | 15 | $317 |
| Phathom Pharmaceuticals, Inc. | 4 | $207 |
| Lilly USA, LLC | 5 | $187 |
| Teva Pharmaceuticals USA, Inc. | 1 | $125 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $123 |
| Astellas Pharma US Inc | 1 | $120 |
| PFIZER INC. | 4 | $80 |
Products named: TREMFYA, REZDIFFRA, SKYRIZI, ENTYVIO, VOQUEZNA, LINZESS, Vyloy, EOHILIA.
Industry payments across NY — which companies pay providers there.
